Boston & New England | February 12, 2021

DivcoWest Tops Off 480K-SF Life Science Project at Cambridge Crossing

Real estate investment firm and developer DivcoWest has announced the topping off of a 480,000-square-foot life sciences property at the 43-acre Cambridge Crossing mixed-use neighborhood at the intersection of the cities of Boston, Cambridge and Somerville.

Located at 250 Water St., biopharmaceutical firm Bristol Myers Squibb has preleased 360,000 square feet at the building, which is slated to be completed in the first quarter of 2022.

Cambridge Crossing is slated to consist of 2 million square feet of laboratory and office space, 2.4 million square feet of residential space and 100,000 square feet of retail space. The project is connected to two stops on the MBTA Green Line. Additional life sciences users at Cambridge Crossing are planned to include Sanofi and Cerevel Therapeutics.

Subscribe to Connect Daily National

For comments, questions or concerns, please contact David Cohen

Connect

Inside The Story

Connect With DivcoWestConnect With Bristol Myers Squibb

About David Cohen

David Cohen is Southeast Editorial Director at Connect Commercial Real Estate. David is a media veteran with more than 10 years of experience in journalism, copywriting and communications across a variety of roles. He is responsible for covering commercial real estate news and trends in the Southeast, Florida, Washington D.C. and Boston at Connect CRE as well as specializing in the Student Housing sector. Prior to joining Connect, David was the editor of Northeast Real Estate Business magazine and Student Housing Business magazine at France Media as well as spending time freelancing for ESPN and the Associated Press in the fast-paced field of live sports event production. He is also an owner and investor in multifamily real estate in Atlanta, GA. David currently resides in Atlanta and graduated from the College of Communication & Information at the University of Tennessee Knoxville.

Order Reprints